
COVID-19 Update: The PlasmAr Trial – Convalescent Plasma vs Placebo
…whom a baseline anti-SARS-Cov-2 IgG antibody level could be obtained the median titer was 1:50 (46.0% of patients had no detectable antibody level) No difference in the distribution of clinical…



